Senior insider sale
Chief Financial Officer at ACUMEN PHARMACEUTICALS, INC. — senior position signals high conviction
$46.4K
24.27K shares
What this filing means
ZUGA MATT plans to sell 24.27K shares of ACUMEN PHARMACEUTICALS, INC. valued at approximately $46.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/21/2026ACC: 0001964306-26-000049
Officer· Chief Financial Officer
Since Jun 2021
24.27K
Shares to sell
$46.4K
Approx. market value
2.47K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
1/17/2026
2.47KTotal acquired2.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/17/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 2.47K | — |
| Total | 2.47K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
6.89K
Market value
$12.5K
1/8/2026
—Completed
Units to sell
5.80K
Market value
$11.6K
1/7/2026
—Completed
Units to sell
5.10K
Market value
$10.0K
1/6/2026
—Completed
Units to sell
4K
Market value
$7.8K
1/5/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.47K
Market value
$4.5K
1/21/2026
Total
Units
24.27K
Value
$46.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/8/2026 | 6.89K | $12.5K | — | Completed |
1/7/2026 | 5.80K | $11.6K | — | Completed |
1/6/2026 | 5.10K | $10.0K | — | Completed |
1/5/2026 | 4K | $7.8K | — | Completed |
| Planned — Approximate Date | ||||
1/21/2026 | 2.47K | $4.5K | NASDAQ | Planned |
| Total | 24.27K | $46.4K | ||